Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 1

Koroner arter hastalığı olan hastalarda miyokardiyal yeniden şekillenme ve iskemiye bir yıllık lovastatin tedavisinin etkisi

Influence of one-year treatment with lovastatin on myocardial remodeling and ischemia in patients with coronary artery disease

Pages
16–21
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In the 1st group there was an improvement of lipid spectrum (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Emerging evidence assumes that statins have a benefit to influence the myocardial remodeling and ischemia in patients with coronary artery disease (CAD).
📊
Key Findings & Data:Methods: This randomized prospective study consisted of 83 patients (46 males; mean age 54.3±6.5 years) with CAD and dyslipidemia.
💡
Conclusion & Impact:Results: In the 1st group there was an improvement of lipid spectrum (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Emerging evidence assumes that statins have a benefit to influence the myocardial remodeling and ischemia in patients with coronary artery disease (CAD). Our aim was to investigate the possible and direct favorable effects of lovastatin on left ventricular (LV) systolic, diastolic function and myocardial ischemia in patients with CAD. Methods: This randomized prospective study consisted of 83 patients (46 males; mean age 54.3±6.5 years) with CAD and dyslipidemia. All patients were randomized to following groups: the 1st group (n=44) received lovastatin (20-60 mg/day), hypolipidemic diet and physical training; the 2nd group (n=39) - hypolipidemic diet and physical training. Lipid spectrum, Doppler-echocardiography, bicycle exercise test and 24-hour ambulatory electrocardiographic monitoring were done at baseline and were repeated after 12 months of treatment. The data were analyzed by using the paired and unpaired Student's t-tests. Results: In the 1st group there was an improvement of lipid spectrum (p

Özet

Koroner arter hastalığı (KAH) ve dislipidemili hastalardaki iskemi ve miyokart yeniden şekillenme üzerine statinlerin yararlı etkileri olduğu kanıtlanmıştır. Amacımız, lovastatinin sol ventrikül (SV) sistolik ve diyastolik fonksiyonları ile miyokart iskemisi üzerine olası ve doğrudan yararlı etkilerini araştırmaktı. Yöntemler: Bu randomize prospektif çalışma, koroner arter ve dislipidemi hastalığı olan 83 hastadan (46 erkek; ortalama yaş, 54.3±6.5 yıl) oluşmaktadır. Bütün hastalar, gruplara randomizeydi: 1. grup (N= 44), 20-60 mg/gün lovastatin aldı, hipolipidemik diyet ve beden eğitimi uygulandı; 2. grup (N=39) - hipolipidemik diyet ve beden eğitimi uygulandı. Başlangıçta lipit spektrumu, Doppler ekokardiyografi, bisiklet egzersiz testi ve 24-saat ambulatuvar elektrokardiyogram izlemesi, yapıldı ve 12 aydan sonra tekrarlandı. Veriler, eşleştirilmiş ve eşleştirilmemiş Student's t-tests kullanarak analiz edildi. Bulgular: Birinci grupta, karaciğer transaminazlarında önemli değişiklikler ve diğer yan etkiler olmaksızın lipit spektrumunda (p

🔖

Cite This Article

LUNEGOVA, O., GOTFRID, I., MIRRAKHIMOV, A., DAVYDOVA, N., MOLDOKEEVA, C., MIRRAKHIMOV, E., KERIMKULOVA, A., NORUZBAEVA, A. (2022). Koroner arter hastalığı olan hastalarda miyokardiyal yeniden şekillenme ve iskemiye bir yıllık lovastatin tedavisinin etkisi. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 1, 16–21. https://ajindex.com/articles/436287

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hague W, Forder P, Simes J, Hunt D, Tonkin A. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Am Heart J 2003; 145: 643-51
  2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6
  3. Cheung BM, Lauder IJ, Lau CP, Kumana CR. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 2004; 57: 640-51
  4. Liao JK, Laufs U. Pleiotropic effects of statins. Ann Rev Pharmacol Toxicol 2005; 45: 89-118
  5. Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003; 108: 839-43
  6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001; 285: 2486-97
  7. Röschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Klin Chem Klin Biochem 1974; 12: 403-7
  8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
  9. Klimov AN, Deev AD, Shestov DB. The assessment of lipid parameters and indexes in ischemic heart disease. Cardiologia 1983; 10: 82-3
  10. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2003; 108: 1146-62
  11. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8
  12. DuBois D, DuBois DF. A formula to estimate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303-11
  13. Froelicher VF. Exercise and the heart. Clinical concepts. 2nd ed. Chicago: Year Book Medical Publishers; 1987
  14. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR